ArticleOpen forum infectious diseases2026
Adverse Events Among People Living With HIV Receiving Dolutegravir-Based Regimens: Findings From a 6-Month Active Pharmacovigilance Study in Uganda.
Collins Ankunda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.